Recently diagnosed with HIV? Click here

Microbicide and vaccine both hit snags

Positive Living article • www.sciencedaily.com • 4 March 2010

PRO 2000, the microbicide gel, has failed to protect women against HIV infection in the largest microbicide study to date.

Meanwhile, scientists seeking to understand how to make an HIV vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIVblocking antibodies, but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature.

Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

From Positive Living

This article was first published in the March 2010 issue of Positive Living — more than one year ago.

While the content of this was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.